- Report
- November 2025
- 150 Pages
Global
From €5496EUR$5,950USD£4,597GBP
- Report
- October 2026
- 487 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- February 2026
- 250 Pages
Global
From €4147EUR$4,490USD£3,469GBP
- Report
- May 2026
- 150 Pages
Global
From €2493EUR$2,699USD£2,085GBP
- Report
- June 2026
- 150 Pages
Global
From €4387EUR$4,750USD£3,670GBP
- Report
- October 2026
- 160 Pages
Global
From €3066EUR$3,320USD£2,565GBP
€3833EUR$4,150USD£3,206GBP
- Report
- November 2025
- 150 Pages
United States
From €3648EUR$3,950USD£3,052GBP
- Report
- October 2026
- 563 Pages
Global
From €5403EUR$5,850USD£4,519GBP
- Report
- November 2025
- 185 Pages
Global
From €4156EUR$4,500USD£3,477GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2576EUR$2,789USD£2,155GBP
- Report
- October 2026
- 160 Pages
Global
From €3066EUR$3,320USD£2,565GBP
€3833EUR$4,150USD£3,206GBP
- Report
- August 2026
- 160 Pages
Global
From €3066EUR$3,320USD£2,565GBP
€3833EUR$4,150USD£3,206GBP
- Report
- March 2026
- 135 Pages
Global
From €4480EUR$4,850USD£3,747GBP
- Report
- September 2026
- 183 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- September 2026
- 189 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- September 2026
- 186 Pages
Global
From €3274EUR$3,545USD£2,739GBP
€3638EUR$3,939USD£3,043GBP
- Report
- July 2026
- 250 Pages
Global
From €4147EUR$4,490USD£3,469GBP
- Report
- February 2026
- 250 Pages
Global
From €4147EUR$4,490USD£3,469GBP
- Report
- July 2025
- 120 Pages
Global
From €5496EUR$5,950USD£4,597GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1385EUR$1,500USD£1,159GBP

The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more